The use of chemotherapy in patients with localized high-grade soft tissue sarcoma (STS) is still under discussion in the sarcoma community. Outside clinical trials, the systemic treatment must be applied on the basis of a patient–physician shared decision [1]. Several studies have been performed with conflicting results, but in two meta-analysis an advantage from the use of chemotherapy has been showed in patients with high-grade, large (>5 cm) and deep seated STS [2, 3].
Titolo: | Chemotherapy of Soft Tissue Sarcomas |
Autore/i: | Ferrari S.; Palmerini E. |
Autore/i Unibo: | |
Anno: | 2019 |
Titolo del libro: | Diagnosis of Musculoskeletal Tumors and Tumor-like Conditions: Clinical, Radiological and Histological Correlations - the Rizzoli Case Archive |
Pagina iniziale: | 323 |
Pagina finale: | 325 |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1007/978-3-030-29676-6_48 |
Abstract: | The use of chemotherapy in patients with localized high-grade soft tissue sarcoma (STS) is still under discussion in the sarcoma community. Outside clinical trials, the systemic treatment must be applied on the basis of a patient–physician shared decision [1]. Several studies have been performed with conflicting results, but in two meta-analysis an advantage from the use of chemotherapy has been showed in patients with high-grade, large (>5 cm) and deep seated STS [2, 3]. |
Data stato definitivo: | 10-nov-2020 |
Appare nelle tipologie: |
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.